0001493152-23-031869.txt : 20230906
0001493152-23-031869.hdr.sgml : 20230906
20230906171717
ACCESSION NUMBER: 0001493152-23-031869
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230718
FILED AS OF DATE: 20230906
DATE AS OF CHANGE: 20230906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stockwell Lynn
CENTRAL INDEX KEY: 0001927032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41395
FILM NUMBER: 231240131
MAIL ADDRESS:
STREET 1: 401 EAST LAS OLAS BLVD.
STREET 2: SUITE 1400
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bright Green Corp
CENTRAL INDEX KEY: 0001886799
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 401 EAST LAS OLAS BLVD.
STREET 2: SUITE 1400
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
BUSINESS PHONE: (201)370-1140
MAIL ADDRESS:
STREET 1: 401 EAST LAS OLAS BLVD.
STREET 2: SUITE 1400
CITY: FT. LAUDERDALE
STATE: FL
ZIP: 33301
4
1
ownership.xml
X0508
4
2023-07-18
0
0001886799
Bright Green Corp
BGXX
0001927032
Stockwell Lynn
1033 GEORGE HANOSH BOULEVARD
GRANTS
NM
87020
1
0
1
0
0
Common Stock
2023-07-18
4
G
0
2500000
0.00
A
67583475
D
Common Stock
2023-08-22
4
G
0
977777
0.00
D
66605698
D
Common Stock
2023-08-31
4
S
0
250000
0.4667
D
66355698
D
Common Stock
2023-09-01
4
J
0
2827960
1.15
A
69183658
D
Warrant (right to buy)
3.00
2023-09-01
4
J
0
2827960
0.13
A
2023-09-01
Common Stock
2827960
2827960
D
These transactions involved a bona fide gift of securities by the Reporting Person's child to the Reporting Person and subsequent bona fide gift of securities by the Reporting Person to family members of the Report Person. No consideration was paid by or to the Reporting Person in connection with these transactions.
This transaction involved an open market sale of the Issuer's Common Stock. Reflects the weighted average price of 250,000 shares of common stock of the Issuer sold by the Reporting Person in multiple transactions on August 31, 2023, with sales prices ranging from $0.4549 to $0.4823 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
In connection with an unsecured line of credit in the form of a note (the "Note") between the Issuer and the Reporting Person, on September 1, 2023, the Issuer and the Reporting Person entered into an agreement pursuant to which the Issuer issued to the Reporting Person (i) 2,827,960 shares (the "Shares") of the Issuer's common stock at a conversion price of $1.15 per share, and (ii) warrants (the "Warrants") to purchase up to 2,827,960 shares of the Issuer's common stock at a conversion price of $0.13 per warrant. The issuance of the Shares and the Warrants was made to settle all amounts of principal interests and other costs under the Note as of August 31, 2023 (the "Repayment Obligation").
The Warrants are exercisable immediately upon issuance at an exercise price of $3.00 per share, and shall expire on the earlier of (i) the date that is 45 days after the closing price of the Common Stock on the Nasdaq Capital Market equals or exceeds $3.00 per share, and (ii) August 31, 2024.
/s/ Lynn Stockwell
2023-09-06